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Abstract
Blood consists of different cell populations with distinct functions and correspondingly, distinct gene expression profiles. In
this study, global miRNA expression profiling was performed across a panel of nine human immune cell subsets
(neutrophils, eosinophils, monocytes, B cells, NK cells, CD4 T cells, CD8 T cells, mDCs and pDCs) to identify cell-type specific
miRNAs. mRNA expression profiling was performed on the same samples to determine if miRNAs specific to certain cell
types down-regulated expression levels of their target genes. Six cell-type specific miRNAs (miR-143; neutrophil specific,
miR-125; T cells and neutrophil specific, miR-500; monocyte and pDC specific, miR-150; lymphoid cell specific, miR-652 and
miR-223; both myeloid cell specific) were negatively correlated with expression of their predicted target genes. These results
were further validated using an independent cohort where similar immune cell subsets were isolated and profiled for both
miRNA and mRNA expression. miRNAs which negatively correlated with target gene expression in both cohorts were
identified as candidates for miRNA/mRNA regulatory pairs and were used to construct a cell-type specific regulatory
network. miRNA/mRNA pairs formed two distinct clusters in the network corresponding to myeloid (nine miRNAs) and
lymphoid lineages (two miRNAs). Several myeloid specific miRNAs targeted common genes including ABL2, EIF4A2, EPC1
and INO80D; these common targets were enriched for genes involved in the regulation of gene expression (p,9.0E-7).
Those miRNA might therefore have significant further effect on gene expression by repressing the expression of genes
involved in transcriptional regulation. The miRNA and mRNA expression profiles reported in this study form a
comprehensive transcriptome database of various human blood cells and serve as a valuable resource for elucidating the
role of miRNA mediated regulation in the establishment of immune cell identity.
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Introduction
Blood is a complex tissue consisting of several cell types with
unique functions and correspondingly, distinct gene expression
profiles. Using genome wide gene expression profiling by
microarray, several groups have succeeded in characterizing the
gene expression profiles of selected immune blood cell populations,
including T cells [1], dendritic cells [2], monocytes [3], B cells [4],
megakaryocytes, erythroblasts and platelets [5]. Several groups
have also isolated and profiled cell subsets from healthy donors’
blood to identify immune cell-specific mRNA transcripts [6,7,8].
Determining the specificity of mRNA expression profiles in blood
cells is clearly important for both understanding the biology of the
immune and hematopoietic systems [9] and for characterizing
blood as an important source of transcriptional biomarkers [10].
However, these profiles represent only a snapshot of gene
expression in blood cells – of greater interest are the dynamic
changes in transcriptional regulation that occur during the
differentiation process, which ultimately leads to gene expression
patterns observed in the differentiated cells. Transcription factors
are classic examples of such transcriptional regulators; the role of
transcription factors in haematopoiesis for example has been
demonstrated in several well-characterized systems, including T-
bet, STAT6, FOXp3 and RORgt in the regulation of T helper cell
differentiation.
Besides transcription factors, there is increasing recognition that
non-protein-coding RNAs can play an equally important role as
modulators of gene expression, which may also impact the
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include small nucleolar RNAs (snoRNAs), small Cajal body
specific RNAs (ScaRNA) and micro-RNAs (miRNA). snoRNAs
are a class of small RNA molecules that primarily guide chemical
modifications of other RNAs, mainly ribosomal RNAs, transfer
RNAs and small nuclear RNAs. There are two main classes of
snoRNA, the C/D box snoRNAs, which are associated with
methylation, and the H/ACA box snoRNAs which are associated
with pseudouridylation. scaRNAs are a specific class of small
nucleolar RNAs that localize to the Cajal bodies and guide the
modification of RNA polymerase II transcribed spliceosomal
RNAs U1, U2, U4, U5 and U12 [11]. miRNAs are small
(,21mer) regulatory RNA molecules encoded in plant and animal
genomes that regulate the expression of target genes by binding to
the 39 untranslated regions of specific mRNAs, thereby triggering
mRNA degradation or translational repression. Of the regulatory
RNA classes, miRNAs have been shown to play an important role
in hematopoiesis and in the immune response ([12,13], reviewed
in [14]), but their relative expression across different cells of the
immune system is not well described. Although previous studies
have measured expression of miRNAs in selected immune cell
systems, i.e. B cells [15], NK cells [16], DCs [17], T lymphocyte
development [18] and differentiation of naive T cells into effector
and memory T cell subsets [19], systematic efforts to profile global
miRNA expression across a diverse panel of immune cell subsets
are lacking.
To characterize more precisely the role of miRNAs in different
immune cells, we performed genome wide miRNA expression
profiling for nine immune cell subsets (neutrophils, eosinophils,
monocytes, B cells, NK cells, CD4 T cells, CD8 T cells, myeloid
dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs)),
isolated from whole blood collected from multiple human donors.
We complemented these data by performing genome wide mRNA
expression profiling on samples from the same donors to enable
accurate identification of genes targeted by specific miRNAs.
Based on growing evidence that many miRNAs cause mRNA
degradation or instability [20], simultaneously measured expres-
sion profiles of miRNAs and the mRNAs they target for
degradation should show an inverse relationship, i.e. a negative
correlation. We identified mRNAs that were both negatively
correlated with miRNA expression and also computationally
predicted to be miRNA targets. In addition, we validated and
enhanced the robustness of the miRNA signatures discovered by
performing a similar experiment on an independent cohort
recruited at the University Hospital of Geneva (HUG). This
yielded a highly confident set of mRNA and miRNA transcripts
specific to each of the studied cell populations. Finally, we used
both the mRNA and miRNA expression profiles to construct a
regulatory network for miRNA-mediated gene expression in
immune blood cells. Our study is unique in its systematic
approach towards the characterization of miRNA and mRNA
expression across various immune cell subsets, and identifies
potential miRNA-mRNA regulatory relationships that may be
relevant for immune cell functions and establishment of their
respective transcriptomic identities.
Results
Identification of cell-type specific miRNA transcripts
Nine cell subsets (CD16+CD66b+ Neutrophils, CD162
CD66b+ Eosinophils, CD14+ Monocytes, CD4+ T cells, CD8+
T cells, CD56+ NK cells, CD19+ B cells, CD123+ pDCs and
CD11c+ mDCs) were isolated from healthy human blood
obtained from five pools of five donors each with the exception
of monocytes, where 10 pools were used (Table S1, the donor
demographic information is available in Table S2). Subjects were
randomized across pools for age and gender. Purity of each
isolated cell subset was greater than 95%, as assessed by flow
cytometry, except for monocytes, CD4 T cells and mDCs for
which the average purity was 94%, 92% and 91% respectively.
Since pooling blood samples could theoretically cause cell
activation, samples were kept at 4uC and were pooled only
immediately before cell subset separation in order to minimize this
risk. In fact, we have chosen to pool samples in order to get
sufficient cell numbers for rare cell types (i.e. dendritic cells
representing less than 1% of the PBMCs) and to decrease sample
variability due to donor-to-donor variation.
To identify cell-type specific small non-coding RNA transcripts,
total RNA was extracted from pooled samples, labeled and
hybridized to Affymetrix miRNA chips to measure miRNA,
snoRNA and scaRNA expression. To ascertain that pooling of
samples had a minimal effect on miRNA expression, we isolated in
parallel selected immune cell subsets (CD4, CD8, B cells, NK cells,
neutrophils, eosinophils, monocytes) from single donors and
compared their miRNA profile with the profile from pooled
samples. Clustering samples by similarity of miRNA expression,
samples from the same cell subsets clustered together indepen-
dently of their origin (pooled or single donors). (Figure S1) The
total number of expressed miRNAs was also similar between
pooled and single donor samples, suggesting that pooled samples
did indeed not differ significantly in their miRNA expression from
single donor samples.
Using data from the pooled samples, 170 of the 7815 human-
specific probesets displayed an average log2 signal value greater
than 7 in at least one cell type and were deemed to be expressed
above background. Probesets were assessed for differential
expression across cell types using ANOVA, and were classified
as specific to one, two or three cell types, based on hierarchical
pair-wise comparisons (see methods). Few transcripts were found
uniquely specific for either CD4+ T cells or CD8+ T cells when
considered as individual cell types, and thus subsequent analyses
considered these two T cell types as a single group ‘‘T cells’’ (see
Methods).
Four small-RNA transcripts were each found to be expressed
specifically in one cell type: miR-378 in monocytes, miR-31 in T
cells, miR-935 in eosinophils and miR-143 in neutrophils
(Figure 1). Five small-RNA transcripts were specifically expressed
in two cell types, whereas nine transcripts were specifically
expressed in three cell types (Table 1). miR-31 and miR-143
were verified to be specifically expressed in T cells and neutrophils
in the single donor data (Figure S2). For the miRNAs unique to
one cell type, miR-378 was found to be 4 fold up-regulated in
monocytes relative to T cells, the cell type in which miR-378 had
the second highest expression level (p*,0.04). miR-31 was
expressed uniquely in T cells (at similar levels in CD4 and CD8
T cells) and was 59.2 fold up-regulated in T cells vs NK cells, the
next highest expressing cell type (p*=9.9e-9). miR-935 was 5.6
fold up-regulated in eosinophils compared to mDCs (p*=0.007).
Finally, we observed that miR-143 was uniquely expressed in
neutrophils, the only cell type where the log2 RMA expression
value was greater than 7. miR-143 was also 9.2 fold more
expressed in neutrophils than in eosinophils; p*=0.0007.
miR-362 and miR-125 were specific to two cells types. miR-362
was 10 fold more expressed in monocytes and pDCs than in the
next highest expressing cell type, T cells. Similarly, miR-125 was
expressed in neutrophils and T cells, 14.1 fold higher than in
eosinophils. Small RNA transcripts specific to three cell types were
expressed in cell types belonging to a common lineage: they were
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cells) or myeloid specific (expressed in monocytes and granulo-
cytes). For the myeloid lineage, we observed miR-223 to be
expressed only in monocytes and granulocytes (fold change=8.1
between monocytes and mDCs; p*=0.02). Like miR-223, miR-
652 was also only expressed in myeloid lineage cells (monocytes
and granulocytes, fold change=3.2; p*=0.04). For the lymphoid
lineage, miR-150 was expressed mainly in B cells, T cells and NK
cells (fold-change=9.4 between NK cells and eosinophils,
p*=0.001). In samples from single donors, miR-150 and miR-
223 were confirmed to be specifically expressed in lymphoid and
myeloid lineage cells respectively (Figure S2). Interestingly, we
observed that miR-155 was specifically expressed in lymphoid
lineage cells but down-regulated in neutrophils, eosinophils and
mDCs. This is consistent with previous reports that miR-155 is
elevated in lymphocytic leukemias and enhances inflammatory T
cell development [21,22]. We observed other lymphocyte-specific
small RNAs, including several snoRNAs like HBII-239 (predicted
to guide the 29O-ribose methylation of 5.8S rRNA on residue U14
[23]), as well as U27 and HBII-429, which have been shown to
have miRNA-like activities [24]. However, their exact function in
lymphoid cells remains to be determined.
Identification of mRNA transcripts regulated by cell type
specific miRNAs
We then set out to determine if any of the identified cell-type
specific miRNAs, which regulate the expression of protein-coding
genes, give rise to cell-type specific mRNA expression patterns. As
a first step, we performed whole genome mRNA expression
profiling on the same set of samples using Affymetrix HG-U133
Plus 2.0 microarrays. Data was normalized by RMA, and
expression data from 3 samples (2 neutrophils, 1 eosinophil) were
excluded because they showed a strong outlier expression profile
as observed after a principal component analysis (data not shown).
Probesets were additionally checked for sequence identity against
current genomic annotation. Probesets that did not map to unique
positions in the genome were discarded as an additional quality
control measure. Similar to the miRNA data, mean probeset
expression was compared across cell-types, and significance
assessed using an ANOVA test. Probesets were judged to be
Figure 1. Cell type specific expression of miRNAs. miRNAs were grouped based on specificity to one, two or three cell types. A) miR-143 and
miR-31 were specific to neutrophils and T cells respectively, while B) miR-362 and miR-125 were specific to monocytes, pDCs and T cells, neutrophils.
C) miR-223 was specific to myeloid lineage cells (neutrophils, eosinophils and monocytes), whereas miR-155 was specific to lymphoid lineage cells
(pDCs, T cells, B cells and NK cells).
doi:10.1371/journal.pone.0029979.g001
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the expression level in the specific cell type(s) was significantly
greater or lesser than expression in all the other cell types (criteria:
p*,0.05, corrected for multiple testing by method of Benjamini-
Hochberg and absolute fold change .4). Probesets up-regulated in
one, two or three cell types were required to be expressed with an
average log2 RMA signal value .7 in those respective cell types.
Similarly, down-regulated probesets were required to be expressed
with a signal value .7 in all other cell types.
Using this approach, we identified 696 genes specifically up- or
down-regulated in one, two or three different cell types (Table 2).
Among those, 542 were specific to one cell type (456 up-regulated
and 86 down-regulated), 109 were specific to two cell types (73 up-
regulated and 36 down-regulated) and 45 were specific to 3 cell
types (34 up-regulated and 11 down-regulated). Expression profiles
for the 542 genes specific to single cell types were subject to
hierarchical clustering (complete linkage using Pearson correlation
as distance) and the results visualized in a heatmap in Figure 2.
The full list is available in Table S3. Similar to the miRNA
analysis, we compared again mRNA expression data from single
donor samples to pooled samples to exclude pooling effects.
Expression profiles of single and pooled donor samples were very
similar with an average correlation .0.62 (Figure S3) and samples
co-clustered in hierarchical clustering by cell-type rather than
sample source (pooled or single donor) (Figure S4), suggesting that
pooling effects on mRNA expression were indeed minimal.
Interestingly, the distribution of genes specifically up-regulated
in single cell types was evenly distributed across cell types ranging
from 117 genes in pDCs to 21 genes in monocytes (Table 3), genes
down-regulated in single cell types showed a different distribution:
of the 86 down-regulated genes, a disproportionate majority of
genes were repressed in neutrophils (61 genes; 71% of all
downregulated genes) in contrast to 0% in monocytes. Genes
down-regulated in two or three cell types followed a similar trend,
where 30 of 47 genes identified were specifically repressed in
neutrophils, suggesting that cell-type specific repression of mRNA
Table 1. miRNAs are specifically expressed in 1, 2 or 3 blood cell subsets.
Affymetrix ID Specific Cell Type Fold Change p* Log2 Expression
hsa-miR-378_st Monocytes 3.96 4.37E-02 9.4
hsa-miR-31_st T cells 59.23 9.90E-09 9.39
hsa-miR-935_st Eosinophils 5.64 7.44E-03 7.67
hsa-miR-143_st Neutrophils 9.16 7.45E-04 9.53
hsa-miR-362-5p_st Monocytes; pDCs 10.18 1.31E-03 7.20; 7.17
hsa-miR-532-5p_st Monocytes; pDCs 5.78 1.09E-02 7.88; 8.85
hsa-miR-500-star_st Monocytes; pDCs 4.68 1.77E-02 7.32; 8.58
hsa-miR-663_st B cells; NK cells 5.71 1.37E-05 9.35; 9.91
hsa-miR-125a-5p_st T cells; Neutrophils 14.09 4.85E-06 7.7; 7.9
hsa-miR-150_st B cells; T cells; NK cells 9.38 1.32E-03 11.74; 12.91; 11.61
HBII-239_st B cells; T cells; NK cells 2.76 3.26E-03 9.06; 8.91; 8.68
HBII-429_st B cells; T cells; NK cells 2.72 3.57E-02 9.85; 9.79; 9.00
HBII-202_st B cells; T cells; NK cells 2.16 1.48E-03 11.3; 11.31; 11.02
U27_st B cells; T cells; NK cells 2.16 4.33E-02 8.76; 8.46; 8.10
U95_st B cells; T cells; NK cells 2.03 1.60E-04 12.16; 12.18; 12.01
hsa-miR-768-5p_st B cells; T cells; NK cells 1.95 2.89E-02 12.47; 12.36; 12.52
hsa-miR-223_st Monocytes; Eosinophils;
Neutrophils
8.05 2.21E-02 8.29; 10.16; 11.06
hsa-miR-652_st Monocytes; Eosinophils;
Neutrophils
3.16 4.08E-02 8.46; 9.42; 8.59
The fold-change is between the highest expressing cell population relative to the next highest expressing cell population (p* is the ANOVA p-value for significance of
this comparison, FDR corrected for multiple testing). The Log2 expression is the average expression observed in the different cell types in the order given in column 3
(specific cell type).
doi:10.1371/journal.pone.0029979.t001
Table 2. 696 transcripts are uniquely expressed by 1, 2 or 3 blood cell subsets.
Number of up-regulated
transcripts
Number of down-regulated
transcripts Total numbers of specific transcripts
1 cell type 456 86 542
2 cell types 73 36 109
3 cell types 34 11 45
Total 563 133 696
doi:10.1371/journal.pone.0029979.t002
Paired miRNA-mRNA Profiling of Immune Cell Subsets
PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29979transcripts occurs predominantly in end-differentiated, mature
neutrophils.
Next, we asked if any mRNA transcripts were significantly
negatively correlated with miRNA expression and at the same
time predicted to be miRNA targets by seed site matching
algorithms. Pair-wise correlations were computed for 1,801
human miRNA probes and 20,367 curated mRNA probesets;
the significance of correlation was assessed using a cutoff of 20.55
(False discovery rate (FDR) 1%, based on 100 permutations). In
parallel, we used a modified version of the TargetScan algorithm
(conservation assessed across human, dog, horse, cow, mouse, rat,
opossum, excluding chicken) to determine miRNA targets by seed
site matching. TargetScan predictions were further cross-checked
against other computational (miRanda and miRDB) and exper-
imental databases (mir2disease, tarbase). TargetScan predictions
confirmed by at least one other database were used as the final list
of predicted miRNA targets. We assessed the degree of overlap
between mRNAs negatively correlated with a given miRNA and
mRNAs predicted to be targets of individual miRNAs. We
identified 94 miRNAs (corresponding to 79 miRNA families,
annotation from mirDB) with significant overlap (FDR 5%, 100
permutations, see methods) (Table S4). Six of these miRNAs (miR-
223, miR-143, miR-150, miR-500, miR-652 and miR-125) were
cell-type specific based on our previous analysis. Interestingly, four
of the six miRNAs were specific to cells of the myeloid lineage
(monocytes, neutrophils and eosinophils), consistent with our
earlier finding that most cell-type specific gene repression occurs in
granulocytes (Table 4).
Validation of predicted miRNA target genes using
external data
To further support our observations, we searched for studies in
which cell-type specific miRNA expression levels were altered by
either over-expression or knock-out, and asked if the genes we had
identified as miRNA targets were correspondingly up- or down-
regulated in response. For miR-223, we found one study by Baek
et al. [25], where the authors investigated the role of miR-223 in
granulopoiesis by performing gene expression and proteomic
profiling of mouse neutrophils obtained from a miR-223 knockout
mouse vs a wild type control. Since miR-223 levels were depleted
in the knockout, we asked if the 82 genes identified as miR-223
targets from our current dataset would correspondingly be up-
regulated in absence of negative regulation by miR-223. 66 of
these 82 genes had matching mouse homologs. By querying
against the Baek dataset, we observed that 11 of 66 genes (16.7%)
were indeed up-regulated, four of them (STIM1, FUBP3, CBX5,
FBXO8) with fold change .1.5, the remaining seven (KPNA3,
TMEM64, LRCH1, SMARCD1, PURA, RASA1, TNRC6B)
with fold change .1.3 (Figure 3A).
Genes identified as miR-223 targets using TargetScan were
mildly up-regulated in response to miR-223 knockout, compared
to all other genes. However, genes negatively correlated with miR-
223 expression in our dataset were significantly more correlated
(fold change .1.3) than similar sized groups of genes randomly
selected from the set of TargetScan predictions (FDR p,0.01,
1000 permutations) (Figure 3B), suggesting that additional filtering
for negative correlation between miRNA and mRNA expression
in our dataset yields an enriched set of miR-223 targets that has
higher probability of being regulated by miR-223 in vivo.
Table 3. 542 uniquely expressed transcripts display distinct distributions across cell types, comparing up vs. down-regulated
genes.
Cell Type Number of up-regulated genes Number of down-regulated genes
Neutrophils 84 (18.4%) 61 (70.9%)
Eosinophils 32 (7.0%) 5 (5.8%)
Monocytes 21 (4.6%) 0 (0%)
mDCs 24 (5.2%) 1 (01.1%)
pDCs 117 (25.7%) 10 (11.6%)
T lymphocytes 29 (6.4%) 2 (2.3%)
B lymphocytes 66 (14.5%) 5 (5.8%)
NK cells 83 (18.2%) 2 (2.3%)
Total 456 86
doi:10.1371/journal.pone.0029979.t003
Figure 2. 542 mRNA transcripts are uniquely up or down-
regulated in one cell type. 696 genes were specifically up or down-
regulated in one, two or three different cell-types, with the majority of
genes (542) uniquely up or down-regulated in a single cell-type.
Transformed expression levels are indicated by color scale, with red
representing relative high expression and green relative low expression.
doi:10.1371/journal.pone.0029979.g002
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As additional validation, an independent set of seven cell subsets
(CD16+CD66b+ Neutrophils, CD162CD66b+ Eosinophils,
CD14+ Monocytes, CD4+ T cells, CD8+ T cells, CD56+ NK
cells and CD19+ B cells) were obtained from a separate panel of
healthy donors at the University Hospital of Geneva (HUG)
(Table S2), using the same protocols for cell isolation and sample
processing as the Roche dataset. Samples were profiled for
miRNA and mRNA expression using the same protocols and were
subject to an identical data analysis workflow. This approach
yielded a total of 54 miRNA probesets specifically up-regulated in
one, two or three cell types in the HUG dataset, with 12 miRNA
probesets previously identified as cell-type specific in the Roche
dataset (The Jaccard coefficient, i.e. the intersection to union ratio,
which measures sample set similarity was 0.17.) If mDCs and
pDCs were excluded from the Roche dataset, the number of cell-
type specific miRNA probesets common to both HUG and Roche
datasets increased to 24 with Jaccard coefficient of 0.37. (Figure 4,
Table S5). All miRNAs reported as specific to single cell types in
the Roche dataset (miR-143, miR-31, miR-935 and miR-378)
remained significant in the HUG dataset, while additional
miRNAs were found to be cell-type specific, most notably miR-
145 in neutrophils, miR-181 in NK cells and miR-146 in T cells
and NK cells. Analysing the HUG mRNA data set in a similar
way as shown above for the Roche data, we identified 672 genes
specifically expressed in one, two or three cell types, of which 416
Table 4. 6 cell-type specific miRNAs are negatively correlated with significant numbers of target mRNAs as predicted by
TargetScan.
Affymetrix ID
Num. Target mRNAs (TargetScan, negatively
correlated) Cell Type specificity
HSA-MIR-223 82 Monocytes; Eosinophils; Neutrophils
HSA-MIR-143 60 Neutrophils
HSA-MIR-150 27 B cells; T cells; NK cells
HSA-MIR-500 25 Monocytes; pDCs
HSA-MIR-652 11 Monocytes; Eosinophils; Neutrophils
HSA-MIR-125A 9 T cells; Neutrophils
doi:10.1371/journal.pone.0029979.t004
Figure 3. Potential miR-223 targets are repressed in a miR-223 2/2 system. A) miR-223 expression across the profiled cell types (bars) is
plotted against the relative expression profile (lines) of 82 genes identified as potential miR-223 targets (TargetScan, significant negative correlation).
Red line represent mean expression profile of target genes, dotted line represents mean expression across cell types. B) 82 genes were identified in
our study as being significant miR-223 targets. We used the data from a previously published miR-223 2/2 system [25] to see if those targets would
correspondingly be de-repressed when miR-223 is knocked-out. 62 of these 82 genes had matching mouse homologs (in red). The change in
expression of these genes was compared against all TargetScan predicted miRNA target genes, which included predicted targets not negatively
correlated with miRNA expression in our dataset (234 genes, in blue). Fold-change for all probe sets is also plotted in this figure as a null distribution
(black).
doi:10.1371/journal.pone.0029979.g003
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(with both mDC and pDC samples removed to enable direct
comparisons). Also similar to the Roche dataset, a large majority of
genes specifically down-regulated in one cell type were repressed
in neutrophils (193 genes, or 91% out of a total of 212 genes).
Next, we applied the same analysis workflow to identify genes
both predicted to be miRNA targets by TargetScan and
significantly negatively correlated with miRNA expression in the
HUG dataset (correlation,20.55, FDR 1%). The genes identified
corresponded to predicted targets of 110 miRNAs, of which 21
miRNAs were specifically expressed in one, two or three cell types
in the HUG dataset (Table S6). Of interest, miR-223, miR-143,
miR-150 and miR-652 replicated as significant in both Roche and
HUG datasets, strengthening the case that these miRNAs may
indeed regulate expression of their respective predicted target
mRNAs.
Construction of a miRNA-mRNA regulatory network
Since we observed that several miRNAs were expressed in the
same cell type, e.g. miR-143, miR-145 and miR-223 are
specifically expressed in neutrophils, we asked if miRNAs specific
to the same cell type would target an overlapping set of genes. A
gene could thus be targeted by multiple miRNAs as part of a
coordinated regulatory mechanism to ensure repression of the
eventual gene product. Furthermore, if these miRNAs were cell-
type specific, targeting by multiple miRNAs could also imply the
presence of redundant mechanisms to repress certain genes to
ensure lineage commitment. To identify the genes targeted by
multiple miRNAs, we compared miRNAs with significant
numbers of negatively correlated target mRNAs from both
Roche and HUG datasets. To obtain a higher confidence set, we
selected only miRNA/target mRNA pairs that replicated across
both Roche and HUG datasets for analysis, and further filtered
this list for cell-type specific miRNA expression in the HUG
dataset. (The HUG dataset was chosen, since it contained a
greater number of cell type specific miRNAs compared to the
Roche dataset). We filtered this list for genes targeted by more
than one miRNA. In each case where a gene was targeted by
multiple miRNAs, genomic coordinates of each seed site match
were checked for overlap, to ensure that the miRNAs were not
targeting the same gene due to seed site similarity (the full list of
genes with respective seed site coordinates is in Table S7). The
resulting miRNA/target mRNA pairs were organized in a
network using Cytoscape [26,27] where edges between miRNA
and mRNA nodes represent a potential regulatory relationship.
The layout of the network was determined using a spring
embedded algorithm, which placed the most highly connected
(multiply targeted) mRNAs in the center of the network while
relegating mRNAs with fewer connections to miRNA nodes to
the periphery (Figure 5). The final network consisted of two
clusters, a large cluster consisting of 9 miRNAs specific to
neutrophils, monocytes and myeloid lineage cells (miR-223, miR-
143, miR-145, miR-25, miR-27, miR-425, miR-17, miR-652 and
miR-191) and a much smaller cluster specific to lymphoid lineage
cells (B, T and NK cells), consisting of miR-150 and miR-29 co-
regulating TET3, ERP44 and VEGFA.
Ranking genes in the myeloid cluster by their connectivity, we
found ABL2, a gene which regulates cytoskeleton remodeling
during cell differentiation, cell division and cell adhesion was
found to be targeted by the largest number of miRNAs (N=5:
miR-223, miR-143, miR-25, miR-27, miR-17), followed by
EIF4A2, EPC1 and INO80D, which were targeted by four
miRNAs each. EIF4A2 is involved in regulation of translation
initiation, whereas EPC1 and INO80D are chromatin remodeling
factors, involved in transcriptional regulation. To determine if
other genes targeted by multiple miRNAs have similar regulatory
functions, we performed Gene Ontology functional enrichment
analysis on 76 mRNAs targeted by at least 2 myeloid specific
miRNAs. Indeed, a large fraction of these miRNAs (32 of 76) were
associated with regulation of expression (GO:0010468, p,9.0E-7,
corrected for multiple testing), suggesting that while the myeloid
specific miRNAs may be few in number (9 miRNAs), they may
exert significant secondary effects on the transcription of other
genes by directly repressing expression of genes involved in
transcriptional regulation.
Figure 4. Significant overlap observed between Roche and
HUG datasets. A) Excluding mDCs and pDCs, 749 genes were
identified as cell-type specific in the Roche dataset, compared to 672 in
HUG dataset. 416 genes were common to both (p,2.2e-16). The
Jaccard coefficient (i.e. the intersection to union ratio), which measures
sample set similarity, is 0.41. B) Excluding mDCs and pDCs, 35 miRNAs
were identified as cell-type specific in the Roche dataset, compared to
54 in HUG dataset. 24 miRNAs were common to both (p,2.2e-16) with
a Jaccard coefficient of 0.37. C) 6 miRNAs were significantly negatively
correlated with their TargetScan predicted target genes in the Roche
dataset, compared to 21 in the HUG dataset. 4 miRNAs were common
to both datasets with a Jaccard coefficient of 0.17.
doi:10.1371/journal.pone.0029979.g004
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In this study, we sought to investigate the regulatory role of
miRNAs in nine immune cell subsets found in peripheral blood.
We performed miRNA profiling on a panel of nine human
immune cell subsets (neutrophils, eosinophils, monocytes, B cells,
NK cells, CD4 T cells, CD8 T cells, mDCs and pDCs) to identify
cell-type specific miRNAs and identified four, five and nine
miRNAs specific to one, two and three cell types, respectively. We
then profiled mRNA expression on the same cell subsets from the
same donors to investigate whether the cell-type specific miRNAs
down-regulated their predicted target genes and found six cell-type
specific miRNA that negatively correlated with expression of their
predicted target genes. These results were validated using an
independent cohort where miRNA and mRNA profiling was
conducted on similar immune cell subsets (HUG dataset). To
further elucidate the functional role of these miRNAs, we
constructed cell-type specific regulatory networks from these
miRNA/mRNA regulatory pairs. Two principal regulatory
networks were found: one network consisting of 9 miRNAs from
myeloid lineage cells and a second network consisting of 2
miRNAs from lymphoid lineage.
Although several groups have measured miRNA expression in
selected immune subsets in previous studies, the primary focus of
the present investigation was to systematically characterize cell-
type specific miRNA expression and its potential impact on
transcription of protein-coding genes. There were relatively few
miRNAs that were found exclusively in a single cell type. We
identified miR-143 as neutrophil specific, miR-31 as T-cell
specific, miR-378 as monocyte specific and miR-935 as eosinophil
specific. Several previous reports have shown that miR-143 is
indeed expressed in neutrophils, and patients with polycythemia
vera have elevated miR-143 expression in their neutrophils [28].
miR-143 and miR-145 are located in close proximity at
chromosome 5q32 and while the pre-miRNA structure has not
been identified, it is suggested that they are co-transcribed [29].
Indeed, we observed that miR-145 was also mainly expressed in
neutrophils (fold change=4.53 in neutrophils vs eosinophils) even
though the difference was not significant. Specificity of miR-31 to
T cells appears to be consistent with its role in T cell lineage
determination. As reported by a previous study, miR-31 inhibits
differentiation of naı ¨ve T cells to T regulatory cells by negatively
regulating FOXP3 expression, binding directly to its potential
target site in the 39 UTR of FOXP3 mRNA. Consequently, miR-
31 is down-regulated in nTreg compared to naı ¨ve CD4
+CD25
2 T
cells [30], permitting FOXP3 expression and establishment of T
regulatory cell identity. Little is known regarding the function of
miR-378 in monocytes, or miR-935 in eosinophils.
Interestingly, miRNAs specific to three cell types displayed an
expression pattern corresponding to the lineage of the cell types:
lymphoid (T cells, B cells, NK cells and pDC) and myeloid
(monocytes, neutrophils, eosinophils and mDC). miR-223 was an
example of a miRNA expressed in myeloid cells, which agreed
with previous studies showing that miR-223 was involved in the
differentiation of myeloid precursors into granulocytes. miR-223
mutant mice also have higher numbers of granulocyte progenitors
in the bone marrow and hypermature neutrophils in the
circulation [31]. On the other hand, miR-150 was found to be
specific in lymphoid cells, also confirming previous reports that
miR150 is highly expressed in mature B and T cells and can be
detected at high levels in the lymph nodes, spleen and the thymus
[32]. The divergence in expression profiles observed between the
cell subsets of distinct lineage origin reinforces the hypothesis that
miRNAs are key regulators of hematopoiesis.
Figure 5. Regulatory network identifying genes that are shared targets of cell-type specific miRNAs. Networks depicting regulatory
interactions between miRNAs and their respective target genes. miRNAs are coloured red, whereas target genes are coloured yellow. An edge from a
miRNA node to a mRNA node indicates that the gene is both predicted to be a miRNA target by TargetScan and significantly negatively correlated
with miRNA expression across the profiled blood cell subsets.
doi:10.1371/journal.pone.0029979.g005
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subsets isolated from the same donors, we identified genes that also
displayed similar specificities to one, two or three cell types and
attempted to correlate the expression of these genes to miRNA
expression profiles. We found 542 genes specific to a single cell
type, with 456 genes up- and 86 genes down-regulated. Unlike the
up-regulated genes, genes specifically down-regulated in a single
cell type were predominantly repressed in neutrophils. Neutrophils
are short-lived cells playing an important role in inflammatory
reactions, with a half-life of 6 to 7 hours in blood. This short life
span might explain why neutrophils have poorly developed
machinery for protein synthesis, and why genes related to
transcription and protein synthesis (i.e. ribosomal protein genes)
are profoundly under-represented. Despite this, neutrophils
maintain active genes responsible for their unique activities and
are able to synthesize RNA and proteins de novo following
activation [33]. A recent study by Rossi et al. describes the
miRNA-ome of most human lymphocyte subsets [34]. miR-125a-
5p, which we found in our study specifically expressed in T cells,
was also found to be expressed by CD4 and CD8 cells, in the study
of Rossi et al. In concordance with their results we also found
expression of miR-150 in all B, T and NK cells subsets. Finally,
they found miR-125b to be highly specific for naı ¨ve CD4 T cells
and to constitute an important regulator of the naı ¨ve state of those
cells; we found this miRNA to be specifically expressed in CD4
and CD8 cells in the lymphocyte compartment.
In correlating miRNA expression with expression of their
predicted mRNA targets, we identified 94 miRNAs that were
likely negative regulators of their respective mRNA targets. Of
these, six miRNAs were cell-type specific, suggesting that these
miRNAs could play a functional role in defining the cell-type
specificity of their respective targets. One of these miRNAs was
miR-223, for which we were able to show that the target genes
identified were correspondingly up-regulated in neutrophils of a
miR-223 gene knockout mouse [25], serving as additional support
that these genes may indeed be modulated by miR-223 in vivo.
This study also showed that mRNAs of most of the highly
responsive proteins were de-repressed already at the myeloid
progenitor stage, suggesting that miR-223 is important already
early in neutrophil differentiation.
As further validation of our approach, we decided to profile the
same cell subsets in an independent test cohort recruited at the
University Hospital of Geneva (HUG). When the same analysis
workflow was applied to the HUG dataset, we identified 54 cell
type specific miRNAs, of which 21 were significantly negatively
correlated with expression of their predicted target genes. Analysis
of the HUG dataset yielded more significant miRNAs and
mRNAs than the Roche dataset, but this was likely due to two
reasons: firstly, the HUG dataset did not include mDCs or pDCs,
which reduced the total number of cell types a miRNA or mRNA
transcript had to be compared against in order to be identified as
cell-type specific. When mDCs and pDCs were removed from the
Roche dataset to ensure direct comparison across datasets, the
agreement between both datasets increased, as measured by the
Jaccard coefficient, from 0.29 to 0.41 for the mRNA data and
from 0.17 to 0.37 for the miRNA data. Secondly and perhaps
more importantly, samples from each cell type in the HUG dataset
were hybridized to microarrays and run on separate days. We
assumed that the biological difference between cell types would be
greater than the technical variation in array quality across scan
dates; however this lack of randomization could have artificially
increased the apparent difference in miRNA expression between
cell types. Scan date and cell-type variability in the HUG miRNA
and mRNA datasets were visualized using principal components
analysis (PCA) (Figure S5). Since each cell type was scanned on a
separate date, the scan date effect was completely confounded with
the cell type effect and could have contributed to additional
separation between samples in the PCA plot. Overlap in terms of
the number of differentially expressed miRNAs could be
optimized via a maximum likelihood approach as developed by
Git et al [35]. In their iMLE algorithm, the authors varied
significance thresholds for each dataset iteratively to obtain the
highest number of differentially expressed ‘truth’ calls across all
compared datasets or platforms. We attempted to apply this
method to the current comparison between Roche and HUG
datasets, but were unable to obtain relevant results, most likely
because only 2 datasets were being compared as opposed to 6
independent datasets from different platforms in Git et al.
miRNAs can act via two mechanisms to cause target gene
repression: translational inhibition and transcript destabilization
and degradation. Transcript destabilization and degradation is
favored when complementarity between the miRNA and the seed
site match in the 39 UTR increases. Indeed, by using negative
correlation between miRNA and mRNA expression to identify
miRNA target genes, we tacitly assume that these miRNA
predominantly act on their targets by favoring the second
mechanism: transcript destabilization and degradation. It remains
to be determined what fraction of miRNA targets are solely
regulated by this mechanism, although a recent study using
ribosome profiling suggested that miRNAs predominantly act in
mammalian cells through decreasing levels of target mRNAs [20].
Another possibility might be that the inverse expression patterns
we observed between miRNAs and their predicted mRNA targets
are due to indirect regulation, which is impossible for us to rule out
but appears highly unlikely.
While the assumption that miRNAs regulate target mRNA
expression via transcript degradation may not be true in general,
in cases where a gene is targeted by multiple miRNAs, cooperative
action between multiple miRNAs could favor transcript degrada-
tion as opposed to translational inhibition. Towards this end, we
constructed a regulatory network of cell-type specific miRNAs and
their putative target genes, which enabled us to identify target gene
‘‘hubs’’, or genes targeted by multiple miRNAs, which increased
their likelihood of being targeted for transcript degradation. The
regulatory network consisted of a small cluster of miRNAs specific
to lymphoid lineage cells (miR-150 and miR-29) and a much
larger cluster of miRNAs specific to myeloid cells. We found ABL2
to be targeted by the largest number of myeloid specific miRNAs.
This was consistent with reports of ABL2 fusion transcripts in
AML cell lines [36], which suggested that increased activity of
transformed ABL2 helped maintain an undifferentiated myeloid
precursor state. Myeloid specific miRNAs may promote differen-
tiation and granulopoiesis by repressing ABL2 levels, disrupting
maintenance of the undifferentiated myeloid precursor state.
Targeting of ABL2 by various miRNAs could be a redundant
mechanism to ensure ABL2 repression in myeloid cells, and it
would be interesting to study whether indeed ABL2 levels could be
modulated in a dose dependent fashion in vivo by perturbing the
expression of one or more of its regulatory miRNAs.
The organization of myeloid miRNAs in the regulatory network
placed miR-223, miR-143 and miR-145 in a central position,
since they targeted several genes in common with other miRNAs.
This suggests that they might play a determinant role in cell-fate
decision during granulopoiesis. Indeed, miR-223, miR-143 and
miR-145 have been shown to be overexpressed in myeloid cells
from polycythemia vera patients in which enhanced erythropoiesis
is observed [28], suggesting that these 3 miRNAs are usually
decreased during erythropoiesis. It would be very interesting to
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their regulation plays a role in erythropoiesis versus granulopoeisis
differentiation.
In conclusion, our study identifies miRNAs, their respective
target genes, and the regulatory role of miRNAs in specific
immune cell subsets. To our knowledge, it is the first study
attempting to simultaneously profile mRNA and miRNA from a
diverse panel of immune cells in a systematic manner. We have
identified strong candidates for miRNA/mRNA regulatory
relationships specific to myeloid and lymphoid cell subsets, which
contribute to our understanding of how miRNA-mediated
regulation can impact the establishment of immune cell identity.
Methods
Ethics Statement
This study was performed in conformity with requirements
approved by the institutional review boards of F.Hoffmann-
LaRoche Ltd and the University Hospital of Geneva. This study
was approved by the institutional review boards at F.Hoffmann-
LaRoche and the University Hospital of Geneva. All participants
were recruited following written informed consent.
Cell isolation
Peripheral blood was obtained from healthy donors with ages
ranging from 15 to 59 and with equal gender distribution. Blood
was drawn in EDTA tubes (BD Vacutainer, Franklin Lakes, NJ,
USA). A nucleated cell suspension was prepared from 50 mls of
whole blood using lymphocyte separation medium (LSM, MP
Biomedicals, LLC Solon, OH, USA). The cell pellet was transferred
to a new tube and lysed with ammonium chloride solution
(PharMLyse, BD Biosciences, Breda, The Netherlands) on ice for
10 minutes. After washing the pellet twice with PBS-2%FBS-1 mM
EDTA, cells were resuspended at 5610
7/mL and neutrophils and
eosinophils were isolated using the EasySepH Human Neutrophil
Enrichment Kit (Stem Cell Technologies, Grenoble, France) and
EasySepH Human Eosinophil Enrichment Kit (Stem Cell Technol-
ogies) respectively according to manufacturer’s instruction. The
PBMCs fraction was washed twice with PBS-2%FBS-1 mM
EDTA. CD14+ monocytes, CD8+ T cells, CD56+ NK cells and
CD19 B cells were isolated using the Human CD14 positive
Selection Kit, Human CD8+ T cells Enrichment Kit, EasySepH
Human CD56+ NK cells Enrichment Kit, EasySepH Human
CD19+ B cells Enrichment Kit (all from Stem Cell Technologies),
respectively, accordingto manufacturer’s instructions. The CD4+ T
cells were isolated from the monocyte-depleted fraction (obtained
during the monocyte isolation) using the EasySepH Human CD4
Positive Selection Kit (Stemcell Technologies) according to
manufacturer’s instructions. Blood dendritic cells were obtained
from a second batch of experiments. Briefly, a nucleated cell
suspension was prepared from EDTA treated whole blood
(,50 mls) using lymphocyte separation medium (LSM, MP
Biomedicals, LLC). The PBMC fraction was washed twice with
PBS-2%FBS-1 mM EDTA and CD123+ plasmacytoid dendritic
cells (pDCs), CD11c+ myeloid dendritic cells (mDCs) and CD14+
monocytes were isolated using the EasySepH Human pDC
Enrichment Kit, a custom EasySepH Human mDC Enrichment
Kit (containing antibodies directed against CD3, CD19, CD14,
CD16, CD19, CD25, CD34, CD56, CD66b, GlyA, CD85g,
CD45RA, CD123 and dextran) and the Human CD14 positive
Selection Kit (all from Stemcell Biotechnologies), respectively,
according to manufacturer’s instructions. When indicated, PBMCs
or granulocytesfrom 5 donorswerepooled followed immediately by
cell subset isolation. The incubation time of cells from different
donors origin was kept to a minimum (never exceeding 30 minutes
at 4uC) in order to minimize cell activation. The purity of the
isolated cell population was assessed by FACS using the following
antibodies: anti-CD3 AF488, anti-CD66b FITC, Lin FITC, anti-
CD14 PE, anti-CD56 PE, anti-CD123 PE, anti-CD45 PE-Cy7,
anti-CD8 PerCP, anti-HLA-DR PerCP, anti-CD19 APC, anti-
CD11c APC, anti-CD4 APC-Cy7, anti-CD16 APC-Cy7 (all from
BD Bioscience), and was .90% for CD4+ T cells and mDCs and
.95% for all other cell types.
RNA isolation
Total RNA, including small non-coding RNAs, was extracted
using the mirVana RNA isolation kit (Ambion, Inc, Austin, TX,
USA), according to manufacturer’s protocol. RNA was quantified
using a ND-1000 spectrophotometer (Nanodrop TechnologyH,
Cambridge, UK) and RNA integrity was assessed using the Agilent
2100 Bioanalyzer (Agilent technologies, Santa Clara, CA, USA).
The 260/280 ratio were between 1.7 and 2.1 and the RINs (RNA
Integrity Numbers) were .6 for all samples.
Microarray processing
For mRNA expression analysis total RNA (100 ng) was
transcribed and labeled into amplified RNA (aRNA) using the
39IVT express kit (Affymetrix Inc., Santa Clara, CA) according to
manufacturer’s instruction on a GCAS (Gene Chip Array Station).
Fragmented and labeled aRNA was hybridized to the Affymetrix
U133 Plus 2.0 chips, according to manufacturer’s instructions.
For miRNA expression analysis total RNA (300 ng) was biotin
labeled using the FlashTag
TM HSR RNA labeling kit for
Affymetrix miRNA arrays (Genisphere LLC., Hatfield, PA,
USA), according to manufacturer’s instructions. Labeled RNA
was hybridized to Affymetrix GeneChip miRNA microarrays,
according to manufacturer’s instructions. The data is available in
GEO under the accession number GSE28492.
Data analysis
The quality of the raw data (CEL files) was assessed in
Bioconductor using 4 metrics: maplot, spatial, boxplot and rle.
Data was then normalized using the robust multi-array average
(RMA) expression measure [37]. Probesets were then annotated
using the latest annotation available in Bioconductor and curated
using an internal Roche probe inspector tool, which updates gene
annotation per probeset based on the latest human genome draft
release. As an additional quality measure, probesets were also
curated using the tool for sequence specificity; probesets mapping
to non-unique locations in the genome were flagged and ignored
in subsequent analysis. A total of 20,367 out of 54,675 probesets
passed the QC and curation process, corresponding to 11,629
unique genes. Using principal component analysis (PCA) to
visualize sample-to-sample variability in miRNA data, we flagged
3 mDC samples (donor pools 16, 17 and 18) as outliers and
excluded them from subsequent analysis. 4 samples from the June
22
nd 2010 scan date were also excluded as outliers (CD4+ T cell
sample from donor pool 2, CD14+ monocyte sample from donor
pool 7, eosinophil sample from donor pool 3 and neutrophil
sample from donor pool 7). For the mRNA data, 1 eosinophil
(donor pool 1) and 2 neutrophil samples (donor pools 1 and 2)
were also flagged as outliers and removed from analysis.
Identification of cell-type specific miRNA and mRNA
transcripts
For miRNA analysis, probesets were filtered for detection by
requiring RMA signal value to be at least greater than 7 in at least
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immune cell subsets were considered in the analysis: T cells
(CD4+, CD8+), B cells (CD19+), NK cells (CD56+), Monocytes
(CD14+), Neutrophils, Eosinophils, mDCs and pDCs. CD4+ and
CD8+ subsets together as ‘T cells’ because few transcripts were
unique to resting CD4+ cells or CD8+ cells only. Transcripts with
significant differential expression across cell subsets were identified
using ANOVA. For each transcript, we ranked the various cell-
types in descending order, i.e. from highest-expressing to lowest-
expressing. miRNAs specifically up or down regulated in 1,2 or 3
cell-types were identified by requiring significant difference in
expression between the highest expressing cell types (or lowest for
cell type specific down-regulation) vs. the next highest cell type
(p,0.05, with Benjamini-Hochberg correction for multiple
testing). A fold-change cutoff was not imposed as a criterion for
cell type specific expression since few miRNAs displayed marked
fold-change differentials from highest/lowest expressing group
relative to next highest/lowest expressing cell type.
For mRNA analysis, transcripts were identified as specifically
up-regulated in 1, 2 or 3 cell types if differences in expression
within the top group were insignificant, whereas difference relative
to the next highest expressing cell-type was at least 4 fold. (p,0.05,
with Benjamini-Hochberg correction for multiple testing). Tran-
scripts specifically down-regulated in 1, 2 or 3 cell types were
identified by applying a similar set of criteria to the lowest
expressing 1, 2 or 3 cell-types.
In both miRNA and mRNA analysis, CD4+ and CD8+ T cells
were considered as a single group: ‘T cells’ because few transcripts
were unique to CD4+ cells or CD8+ cells only. For example, the
only mRNA transcript specific to CD8 T cells was CD8B. CD8A
was expressed by CD8+ T cells and NK cells with a higher level in
CD8+ T cells but the difference was not significant. Three other
genes previously identified to be CD8+ T cell-specific (DKK3,
CD248 and T-cell receptor alpha V gene segment TRAV1-2) [8]
could not be detected in our study (signal intensity below log2 7o r
non-specific probeset mapping to genome).
Platform comparison between Roche and HUG
Human Reference RNA (Agilent technologies) and First Choice
Human RNA (Ambion) were used as a RNA source respectively
for mRNA and miRNA platform validation between the two sites.
Arrays from 6 technical replicates for mRNA and 4 for miRNA
were processed at Roche and at HUG and evaluated to assess the
level of comparability between the two platforms. Data were
preprocessed separately for Roche and HUG arrays as described
above (RMA normalization, internal probe curation and QC). In
order to identify problematic arrays, QC was performed before
and after pre-processing. QC checks included: Evaluation of the
intensity profiles, M and A plots, between-arrays comparisons of
average background, scale factor, GAPDH 39/59 ratios, RNA
degradation (based on RNA digestion plots), PLM (probe level
models) methods (e.g. RLE, NUSE) and multivariate expression
profiling obtained by principal component analysis (PCA)
available in the Bioconductor affy package in the R programming
environment.
Correlation of miRNA and target mRNA expression
profiles
Expression profiles for all 20,367 probesets and 1,801 human
miRNA probes were Z-score transformed to have zero mean and
unit variance across cell-types. To identify miRNAs that
significantly negatively correlate with target mRNA expression,
we computed the Pearson correlation for each miRNA/mRNA
probeset pair. Pairs displaying significant negative correlation
(,20.55) were selected for further analysis. The value for the
correlation cutoff (20.55) was determined by setting a FDR of 1%
cutoff on the results of 100 permutations - in each permutation,
cell-type labels were randomized and miRNA-mRNA pairwise
correlations recomputed.
Target genes for miRNA were predicted using a Roche
modified TargetScanS algorithm and further cross-checked with
predictions from 2 other algorithms (miRanda and miRDB) and
experimentally validated targets from mir2disease and from
tarbase. Overlap between mRNAs significantly negatively corre-
lated with miRNA expression and mRNAs predicted to be
miRNA targets were calculated for each miRNA. Significance of
overlap was quantified by performing 100 permutations to
estimate false discovery rates. The number of predicted mRNA
targets per miRNA was fixed in each permutation, while their
identities were randomized. FDR cutoffs of 1% and 5% were
applied to obtain lists of miRNAs with significant numbers of
predicted mRNA targets that are also negatively correlated in
expression.
Supporting Information
Figure S1 Clustering of single donor and pooled donor
samples based on correlation of miRNA expression
profiles. Samples from single or pooled donors are listed in the
same order on x and y axes. Samples from pooled donors are
indicated by ‘‘Pool’’ followed by the donor pool number, cd19: B
cells, cd56: NK cells, cd4: CD4+ Tcells, cd8: CD8+ T cells, cd14:
Monocytes, eosino: Eosinophils, neutro: Neutrophils. Samples
from single donors are indicated by cell type, followed by single
donor index. Correlation between samples based on miRNA
expression is represented by the heatmap coloring scheme, ranging
from anti-correlated (Blue: 21) to correlated (Red: 1).
(TIFF)
Figure S2 miR-31, miR-143, miR-223 and miR-150 are
confirmed to be cell type specific, using data from single
donor samples. Expression levels for miR-31, miR-143, miR-
223 and miR-150 (Log2, mean 6 SEM) are plotted across a panel
of immune cell subsets, for samples obtained from single donors
(dark shaded bars) and pooled donors (light shaded bars).
(TIFF)
Figure S3 Average correlation between single and
pooled donor samples is .0.62 across cell types.
Correlations were computed between mRNA expression profiles
of single and pooled donor samples, for each cell type. The
distributions of correlation values for each cell type are plotted as
histograms, with the average correlation listed for each cell type.
(TIFF)
Figure S4 Clustering of single donor and pooled donor
samples based on correlation of mRNA expression
profiles. Samples from single or pooled donors are listed in the
same order on x and y axes. Samples from pooled donors are
indicated by ‘‘Pool’’ followed by the donor pool number, cd19: B
cells, cd56: NK cells, cd4: CD4+ Tcells, cd8: CD8+ T cells, cd14:
Monocytes, eosino: Eosinophils, neutro: Neutrophils. Samples
from single donors are indicated by cell type, followed by single
donor index. Correlation between samples based on mRNA
expression is represented by the heatmap coloring scheme, ranging
from anti-correlated (Blue: 21) to correlated (Red: 1).
(TIFF)
Figure S5 PCA plots of miRNA and mRNA data from
the HUG dataset. Principal component analysis (PCA) was
performed on mRNA and mRNA expression data from the HUG
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different shapes by cell type.
(TIFF)
Table S1 Sample information.
(XLS)
Table S2 Blood Donor information.
(XLS)
Table S3 List of 696 mRNA transcripts specific to 1, 2 or
3 blood cell subsets.
(XLS)
Table S4 List of 94 miRNAs significantly negatively
correlated with target mRNA expression (TargetScan).
(XLS)
Table S5 List of 55 miRNAs which are cell-type specific
in the HUG dataset.
(XLS)
Table S6 List of 21 miRNAs which are cell-type specific
in HUG dataset and negatively correlate with target
mRNA expression (TargetScan).
(XLS)
Table S7 List of target genes that are regulated by
multiple miRNAs.
(XLS)
Acknowledgments
We are grateful to Dr Patrick Descombes (Genomic platform of the
University of Geneva) for his technical help for scanning miRNA
microarrays processed at HUG.
Author Contributions
Conceived and designed the experiments: FA DC. Performed the
experiments: FA. Analyzed the data: FA DC. Contributed reagents/
materials/analysis tools: PR HB SS ME LB GDP MFR. Wrote the paper:
FA DC. Isolated the cells at HUG: MD AC. Processed the micorarrays at
HUG: MD AC. Designed research: TB TM MFR BR MEB DH. Directed
work: JV TM.
References
1. Wang M, Windgassen D, Papoutsakis ET (2008) Comparative analysis of
transcriptional profiling of CD3+, CD4+ and CD8+ T cells identifies novel
immune response players in T-cell activation. BMC Genomics 9: 225.
2. Lindstedt M, Lundberg K, Borrebaeck CA (2005) Gene family clustering
identifies functionally associated subsets of human in vivo blood and tonsillar
dendritic cells. J Immunol 175: 4839–4846.
3. Zhao C, Zhang H, Wong WC, Sem X, Han H, et al. (2009) Identification of
novel functional differences in monocyte subsets using proteomic and
transcriptomic methods. J Proteome Res 8: 4028–4038.
4. Ehrhardt GR, Hijikata A, Kitamura H, Ohara O, Wang JY, et al. (2008)
Discriminating gene expression profiles of memory B cell subpopulations. J Exp
Med 205: 1807–1817.
5. Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M,
et al. (2007) Comparative gene expression profiling of in vitro differentiated
megakaryocytes and erythroblasts identifies novel activatory and inhibitory
platelet membrane proteins. Blood 109: 3260–3269.
6. Abbas AR, Baldwin D, Ma Y, Ouyang W, Gurney A, et al. (2005) Immune
response in silico (IRIS): immune-specific genes identified from a compendium
of microarray expression data. Genes Immun 6: 319–331.
7. Liu SM, Xavier R, Good KL, Chtanova T, Newton R, et al. (2006) Immune cell
transcriptome datasets reveal novel leukocyte subset-specific genes and genes
associated with allergic processes. J Allergy Clin Immunol 118: 496–503.
8. Watkins NA, Gusnanto A, de Bono B, De S, Miranda-Saavedra D, et al. (2009)
A HaemAtlas: characterizing gene expression in differentiated human blood
cells. Blood 113: e1–9.
9. Chaussabel D, Pascual V, Banchereau J (2010) Assessing the human immune
system through blood transcriptomics. BMC Biol 8: 84.
10. Burczynski ME, Dorner AJ (2006) Transcriptional profiling of peripheral blood
cells in clinical pharmacogenomic studies. Pharmacogenomics 7: 187–202.
11. Darzacq X, Jady BE, Verheggen C, Kiss AM, Bertrand E, et al. (2002) Cajal
body-specific small nuclear RNAs: a novel class of 29-O-methylation and
pseudouridylation guide RNAs. Embo J 21: 2746–2756.
12. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate
hematopoietic lineage differentiation. Science 303: 83–86.
13. O’Connell RM, Chaudhuri AA, Rao DS, Gibson WS, Balazs AB, et al. (2010)
MicroRNAs enriched in hematopoietic stem cells differentially regulate long-
term hematopoietic output. Proc Natl Acad Sci U S A 107: 14235–14240.
14. O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and
pathological roles for microRNAs in the immune system. Nat Rev Immunol 10:
111–122.
15. Basso K, Sumazin P, Morozov P, Schneider C, Maute RL, et al. (2009)
Identification of the human mature B cell miRNome. Immunity 30: 744–752.
16. Bezman NA, Cedars E, Steiner DF, Blelloch R, Hesslein DG, et al. (2010)
Distinct requirements of microRNAs in NK cell activation, survival, and
function. J Immunol 185: 3835–3846.
17. Kuipers H, Schnorfeil FM, Brocker T (2010) Differentially expressed
microRNAs regulate plasmacytoid vs. conventional dendritic cell development.
Mol Immunol.
18. Neilson JR, Zheng GX, Burge CB, Sharp PA (2007) Dynamic regulation of
miRNA expression in ordered stages of cellular development. Genes Dev 21:
578–589.
19. Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, et al. (2007) miRNA
profiling of naive, effector and memory CD8 T cells. PLoS One 2: e1020.
20. Guo H, Ingolia NT, Weissman JS, Bartel DP (2010) Mammalian microRNAs
predominantly act to decrease target mRNA levels. Nature 466: 835–840.
21. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, et al. (2011)
Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20:
589–599.
22. O’Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, et al. (2010)
MicroRNA-155 promotes autoimmune inflammation by enhancing inflamma-
tory T cell development. Immunity 33: 607–619.
23. Huttenhofer A, Kiefmann M, Meier-Ewert S, O’Brien J, Lehrach H, et al.
(2001) RNomics: an experimental approach that identifies 201 candidates for
novel, small, non-messenger RNAs in mouse. Embo J 20: 2943–2953.
24. Brameier M, Herwig A, Reinhardt R, Walter L, Gruber J (2010) Human box C/
D snoRNAs with miRNA like functions: expanding the range of regulatory
RNAs. Nucleic Acids Res.
25. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, et al. (2008) The impact of
microRNAs on protein output. Nature 455: 64–71.
26. Cline MS, Smoot M, Cerami E, Kuchinsky A, Landys N, et al. (2007)
Integration of biological networks and gene expression data using Cytoscape.
Nat Protoc 2: 2366–2382.
27. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al. (2003) Cytoscape: a
software environment for integrated models of biomolecular interaction
networks. Genome Res 13: 2498–2504.
28. Slezak S, Jin P, Caruccio L, Ren J, Bennett M, et al. (2009) Gene and
microRNA analysis of neutrophils from patients with polycythemia vera and
essential thrombocytosis: down-regulation of micro RNA-1 and -133a. J Transl
Med 7: 39.
29. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, et al. (2009) miR-
145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460:
705–710.
30. Rouas R, Fayyad-Kazan H, El Zein N, Lewalle P, Rothe F, et al. (2009) Human
natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in
FOXP3 expression. Eur J Immunol 39: 1608–1618.
31. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, et al. (2008)
Regulation of progenitor cell proliferation and granulocyte function by
microRNA-223. Nature 451: 1125–1129.
32. Zhou B, Wang S, Mayr C, Bartel DP, Lodish HF (2007) miR-150, a microRNA
expressed in mature B and T cells, blocks early B cell development when
expressed prematurely. Proc Natl Acad Sci U S A 104: 7080–7085.
33. Beaulieu AD, Paquin R, Rathanaswami P, McColl SR (1992) Nuclear signaling
in human neutrophils. Stimulation of RNA synthesis is a response to a limited
number of proinflammatory agonists. J Biol Chem 267: 426–432.
34. Rossi RL, Rossetti G, Wenandy L, Curti S, Ripamonti A, et al. (2011) Distinct
microRNA signatures in human lymphocyte subsets and enforcement of the
naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 12:
796–803.
35. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, et al. (2010)
Systematic comparison of microarray profiling, real-time PCR, and next-
generation sequencing technologies for measuring differential microRNA
expression. Rna 16: 991–1006.
36. Griesinger F, Janke A, Podleschny M, Bohlander SK (2002) Identification of an
ETV6-ABL2 fusion transcript in combination with an ETV6 point mutation in a
T-cell acute lymphoblastic leukaemia cell line. Br J Haematol 119: 454–458.
37. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, et al. (2003) Summaries
of Affymetrix GeneChip probe level data. Nucleic Acids Res 31: e15.
Paired miRNA-mRNA Profiling of Immune Cell Subsets
PLoS ONE | www.plosone.org 12 January 2012 | Volume 7 | Issue 1 | e29979